Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents

Figure 1.
Figure 1. Prescriptions for gabapentin, by diagnostic category.

Estimates of diagnosis-linked prescribing provided by Pfizer, Inc. (2–4). Each diagnosis was assigned to a diagnostic category by the authors. *Adjunctive treatment of epilepsy in adults older than age 12 years was the only U.S. Food and Drug Administration–approved use of gabapentin during the time period shown.

This Article

  1. Ann Intern Med August 15, 2006 vol. 145 no. 4 284-293
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. December 1, 2009, 151 (11)
  1. Alert me to current issues